Item 8 Financial Statements As Reported
Stockholders' Equity
(In millions, except per share amounts)
FYE 6/30/20
FYE 6/30/21
FYE 6/30/22
1
Common stock and paid-in capital
2
Balance, beginning of period
78,520
80,552
83,111
3
Common stock issued
1,343
1,963
1,841
4
Common stock repurchased
(4,599)
(5,539)
(5,688)
5
Stock-based compensation expense
5,289
6,118
7,502
6
Other, net
(1)
17
173
7
Balance, end of period
80,552
83,111
86,939
8
Retained earnings
9
Balance, beginning of period
24,150
34,566
57,055
10
Net income
44,281
61,271
72,738
11
Common stock cash dividends
(15,483)
(16,871)
(18,552)
12
Common stock repurchased
(18,382)
(21,879)
(26,960)
13
Cumulative effect of accounting changes
0
(32)
0
14
Balance, end of period
34,566
57,055
84,281
15
Accumulated other comprehensive income (loss)
16
Balance, beginning of period
(340)
3,186
1,822
17
Other comprehensive income (loss)
3,526
(1,374)
(6,500)
18
Cumulative effect of accounting changes
0
10
0
19
Balance, end of period
3,186
1,822
(4,678)
20
Total stockholders’ equity
118,304
141,988
166,542
21
Cash dividends declared per common share
2
2
2
There are no rows in this table
The 10-K Elves 🧝♂️🧝♀️ are putting together “10-K Elf” Reports for the following “Magnificent 7” (A.K.A. “Mag 7”) stocks.
Want to print your doc?
This is not the way.
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.